Pearl Pathways announces the hiring of Beckinam Nowatzke as a Quality Assurance and Regulatory Affairs (QA/RA) Advisor. Nowatzke brings over 17 years of experience across biotechnology, pharmaceutical, CRO, and medical device industries.
Beckinam Nowatzke, MSc, RAC
An accomplished quality & regulatory affairs professional, Beckinam is a recognized leader of quality assurance compliance processes of preclinical, clinical, medical device, and combination products, including implementation of a GLP-compliant quality assurance units, QSR-compliant and ISO 13485 Quality Management Systems, and GCP-compliant quality improvement activities. Nowatzke is a strategic regulatory professional with a proven record of success, including multiple 510(k) clearances, CE certifications, Technical File management, product acquisition due diligence and integration.
Prior to joining Pearl Pathways, Beckinam was the Director of Regulatory Compliance & Clinical Research for Wenzel Spine. Previously, Beckinam held positions with Amgen, Biomimetic Therapeutics, CEDRA Clinical Research (now WCT) and LDR Spine (now part of Zimmer Biomet). She earned her B.S. in Biology from Loyola Marymount University and her M.S. in Regulatory Sciences from the University of Southern California. Learn more about Nowatzke by viewing her full biography.